查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1984209

核酸樣品製備市場：按產品、工作流程類型、自動化程度、應用和最終用戶分類－2026-2032年全球市場預測

Nucleic Acid Sample Preparation Market by Product, Workflow Type, Automation, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，核酸樣品製備市場價值將達到 28.6 億美元，到 2026 年將成長至 30.1 億美元，到 2032 年將達到 42.1 億美元，複合年成長率為 5.66%。

主要市場統計數據
基準年 2025 28.6億美元
預計年份：2026年 30.1億美元
預測年份 2032 42.1億美元
複合年成長率 (%) 5.66%

了解核酸樣品製備在實現可靠的分子工作流程和操作擴充性的策略性作用。

核酸樣品製備生態系處於生命科學、臨床診斷和工業生物技術的交匯點，是分子工作流程中關鍵預分析步驟的基礎。提取化學、自動化和整合儀器的進步，已將樣品製備從一項常規實驗室任務提升為一項策略性環節，從而驅動下游流程的處理能力、可重複性和數據品質。隨著定序、基於PCR的診斷和高內涵篩檢對更高純度核酸和更大樣品處理能力的需求不斷成長，樣品製備階段的選擇對檢測靈敏度、週轉時間和操作效率有著至關重要的影響。

自動化、化學和檢驗的工作流程的創新如何重新定義樣品製備實踐和供應商生態系統。

近年來，核酸樣本製備領域經歷了變革性的變化，技術創新和不斷變化的使用者需求重塑了供應商的策略和實驗室的操作流程。自動化技術已從獨立的機器人附加元件發展成為涵蓋提取、純化和品管步驟的整合平台，使實驗室能夠在不相應增加人工的情況下擴大操作規模。除了硬體的進步，化學技術的改進，例如結合能力更強的樹脂和最佳化的裂解緩衝液，也減少了抑制劑的使用，提高了產量穩定性，並直接影響了下游檢測的性能。

評估近期關稅措施對樣品製備價值鏈中的設備、試劑和製造地的營運和供應鏈影響。

美國貿易政策的轉變以及2025年推出的關稅措施，正給核酸樣本製備領域的供應商和檢查室客戶帶來微妙的營運壓力。影響專用設備、進口試劑以及自動化萃取系統特定組件的關稅，可能導致依賴全球供應鏈的檢查室總體成本上升，並改變其籌資策略。為此，許多機構正在重新審視其採購流程，考慮供應商多元化，並增加關鍵耗材的安全庫存，以降低短期波動風險。

我們分析產品、工作流程、應用程式、最終用戶和自動化領域的趨勢，以確定差異化的採用促進因素和供應商定位機會。

透過從產品類型、工作流程類型、應用、最終用戶和自動化等維度對市場進行細分，供應商和買家都能發現其中的潛在機會和限制。產品細分涵蓋儀器、試劑盒、試劑和服務。儀器包括自動化萃取系統、離心機和真空歧管，以滿足不同的處理能力和整合需求。試劑盒包括DNA萃取試劑盒、RNA萃取試劑盒和病毒核酸萃取試劑盒，這些試劑盒的設計旨在適應特定的樣品基質和監管要求。試劑包括結合樹脂、洗脫緩衝液、裂解緩衝液和洗滌緩衝液，這些試劑決定了純度和產量特性。服務包括合約研究和客製化提取服務，為沒有內部設施的機構提供柔軟性。這些產品差異會影響採購決策、驗證計畫和供應商選擇標準。

本檢驗了區域法規結構、採購實踐和製造能力如何影響主要全球市場的採用趨勢和供應商策略。

區域趨勢對核酸樣本製備領域的籌資策略、法規遵循和創新應用有顯著影響。在美洲，市場對與臨床診斷的整合、轉化研究應用以及高通量自動化有著強勁的需求，而採購週期通常與醫保報銷政策和公共衛生優先事項緊密相關。這為經過驗證的試劑盒和整合儀器平台提供了有利環境，尤其是在結合可靠的技術支援和嚴格的法規文件時。此外，該地區各國法規結構的差異也會影響診斷工作流程的實施時間。

透過平台互通性、檢驗的耗材、服務能力和永續性措施來評估競爭差異化。

核酸樣本製備領域的競爭趨勢是由技術差異化、豐富的耗材產品組合以及提供端到端檢驗工作流程的能力共同驅動的。領先的儀器製造商透過平台間的互通性、可擴展的擴充性以及能夠減少臨床和高通量研究客戶停機時間的服務網路來脫穎而出。試劑盒和試劑供應商則在與主流儀器的整合便捷性、對多種檢體類型的穩健性以及由臨床和研究用例支援的檢驗資料強度方面展開競爭。包括合約研究組織 (CRO) 和客製化提取實驗室在內的服務供應商，透過提供針對特定檢體類型的檢驗流程和快速週轉時間，正在開闢獨特的細分市場。

為供應商和檢查室管理人員提供切實可行的策略，以加快部署速度，降低供應鏈風險，並使經營模式與客戶工作流程保持一致。

產業領導企業可以透過推進一系列目標明確、切實可行的舉措，將不斷變化的市場動態轉化為策略優勢。首先，優先考慮模組化平台設計和開放原始碼互通性，可以拓展可用用例範圍，緩解買家對供應商鎖定的擔憂，並最終擴大商業性覆蓋率。其次，投資檢驗的端到端工作流程和完善的技術文檔，可以加快客戶導入速度，縮短價值實現時間，這對臨床檢查室客戶尤其重要。第三，分散生產和採購地點，可以降低關稅帶來的成本壓力，同時增強應對市場干擾的能力。

嚴格的混合研究通訊協定，結合了對從業人員的訪談、技術文獻、監管趨勢分析和交叉檢驗，確保了對該行業的深刻洞察。

本分析的研究途徑結合了第一手和第二手調查，以確保對主題調查結果進行三角檢驗。第一手調查資料包括對臨床檢查室營運經理、學術機構採購經理、受託研究機構技術經理以及設備和試劑供應商產品經理的結構化訪談。這些訪談重點在於實際應用中的挑戰、檢驗的考慮因素以及採購優先事項。第二手數據包括關於萃取化學的同行評審文獻、與臨床診斷相關的監管指導文件、展示創新路徑的專利申請以及設備供應商的技術手冊，以了解其整合能力。

自動化、經過驗證的耗材和強大的採購系統相結合，整合了提高分子檢測性能的策略要求。

核酸樣本製備在分子診斷生態系統中扮演著至關重要的角色，提取化學、自動化和經驗證的工作流程的改進將直接影響診斷靈敏度、檢測可重複性和操作效率。該領域的發展趨勢將繼續受到技術整合的影響，包括整合到平台中的硬體、耗材和軟體，以及受區域法規、關稅環境和機構優先事項驅動的採購行為轉變。能夠使其產品藍圖與客戶面臨的挑戰（例如檢驗時間、供應可靠性和整體擁有成本）相符的供應商，將更有利於確保持續的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：核酸樣品製備市場：依產品分類

  • 裝置
    • 自動提取裝置
    • 離心機
    • 真空歧管
  • 成套工具
    • DNA萃取試劑盒
    • RNA萃取試劑盒
    • 病毒核酸萃取試劑盒
  • 試劑
    • 黏合樹脂
    • 洗脫緩衝液
    • 溶解緩衝液
    • 洗滌緩衝液
  • 服務
    • 合約研究
    • 客製化提取服務

第9章：依工作流程類型分類的核酸樣品製備市場

  • DNA萃取
    • 列式法
    • 磁珠法
    • 有機萃取
  • 微生物萃取
    • 化學溶解
    • 機械溶解
  • 質體萃取
    • 鹼溶解
    • SDS法
  • 病毒核酸萃取

第10章：核酸樣品製備市場：自動化驅動

  • 全自動
  • 手動的
  • 半自動

第11章：核酸樣品製備市場：依應用領域分類

  • 臨床診斷
  • 藥物發現與開發
  • 法醫學分析
  • 基因組調查
  • 個人化醫療

第12章 核酸樣品製備市場：依最終用戶分類

  • 學術研究機構
  • 臨床檢查室
  • 法醫學研究所
  • 工業研究院
  • 製藥和生物技術公司

第13章：核酸樣品製備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：核酸樣品製備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 核酸樣品製備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國核酸樣品製備市場

第17章：中國核酸樣品製備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Bionano Genomics
  • BIONEER CORPORATION
  • Blue-Ray Biotech Corp.
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • MP Biomedicals, LLC
  • Nanjing Vazyme Biotech Co.,Ltd.
  • Norgen Biotek Corp.
  • Opentrons Labworks, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • RevoluGen Ltd
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5C6F41F5B02F

The Nucleic Acid Sample Preparation Market was valued at USD 2.86 billion in 2025 and is projected to grow to USD 3.01 billion in 2026, with a CAGR of 5.66%, reaching USD 4.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.86 billion
Estimated Year [2026] USD 3.01 billion
Forecast Year [2032] USD 4.21 billion
CAGR (%) 5.66%

Understanding the strategic role of nucleic acid sample preparation in enabling reliable molecular workflows and operational scalability

The nucleic acid sample preparation ecosystem sits at the intersection of life sciences, clinical diagnostics, and industrial biotechnology, serving as the essential pre-analytical backbone for molecular workflows. Advances in extraction chemistry, automation, and integrated instruments have elevated sample prep from a routine laboratory task to a strategic enabler of throughput, reproducibility, and downstream data quality. As sequencing, PCR-based diagnostics, and high-content screening continue to demand purer nucleic acids and higher sample throughput, the choices made at the sample preparation stage materially influence assay sensitivity, turnaround time, and operational efficiency.

Stakeholders across academic research, clinical labs, forensic units, and biopharma development are increasingly evaluating sample preparation through the twin lenses of scalability and compliance. This shift reflects broader industry priorities including rapid diagnostic readiness, reproducible research, and cost-effective platform deployment. Consequently, vendors and end users alike are investing in modular instrument platforms, validated kits, and standardized protocols that reduce variability. The narrative of nucleic acid sample preparation is therefore not static; it is a dynamic field driven by technological refinement, evolving regulatory expectations, and expanding application domains that together set the context for strategic decisions in procurement, R&D, and clinical deployment.

How innovations in automation, chemistry, and validated workflows are redefining sample preparation practices and vendor ecosystems

Recent years have seen transformative shifts across the nucleic acid sample preparation landscape, where technological innovation and changing user demands converge to reshape vendor strategies and laboratory practices. Automation has moved beyond single-use robotic add-ons to integrated platforms that combine extraction, purification, and quality control steps, enabling laboratories to scale without proportionate increases in hands-on time. Parallel to hardware evolution, chemistry improvements such as enhanced binding resins and optimized lysis buffers have reduced inhibitory substances and improved yield consistency, directly impacting downstream assay performance.

Another important shift is the proliferation of workflow-specific kits and validated protocols tailored to sample types and regulatory environments. This trend has been driven by the need for reproducibility in clinical diagnostics and the demand for plug-and-play solutions in decentralized testing environments. Additionally, the rise of magnetic bead-based methods as a default for many workflows has prompted a reassessment of consumable supply chains, with users seeking multi-vendor compatibility and open-platform reagents. Taken together, these changes are creating a more modular, interoperable ecosystem where rapid deployment and protocol standardization are prioritized alongside raw performance.

Assessing the operational and supply chain ramifications of recent tariff actions on instruments, reagents, and manufacturing footprints within the sample preparation value chain

Policy shifts and tariff measures introduced in 2025 within United States trade policy have introduced nuanced operational pressures for suppliers and laboratory customers involved in nucleic acid sample preparation. Tariffs that affect specialized instruments, imported reagents, and certain components used in automated extractors have the potential to increase landed costs and alter sourcing strategies for laboratories that rely on global supply chains. In response, many organizations are reassessing their procurement footprints, exploring diversified supplier panels, and increasing safety stock for critical consumables to mitigate near-term volatility.

Beyond procurement, tariff-related changes can accelerate regionalization trends as manufacturers evaluate the trade-offs between centralized production and localized manufacturing to preserve cost competitiveness. This has implications for lead times, quality control frameworks, and regulatory compliance, particularly where local production requires new validation steps or changes in reagent formulations. Importantly, the cumulative impact of tariffs extends to contract research providers and service laboratories that operate on thin margins; these entities may pass increased costs downstream or renegotiate service contracts to maintain viability. In sum, trade policy developments are prompting a strategic recalibration across the value chain, characterized by supply diversification, manufacturing localization, and revised inventory management practices.

Parsing product, workflow, application, end user, and automation segment dynamics to reveal differentiated adoption drivers and vendor positioning opportunities

Deconstructing the market along product, workflow type, application, end user, and automation axes reveals nuanced opportunities and constraints for vendors and buyers alike. Product segmentation spans instruments, kits, reagents, and services, where instruments encompass automated extractors, centrifuges, and vacuum manifolds that address different throughput and integration needs; kits include DNA extraction kits, RNA extraction kits, and viral nucleic acid extraction kits designed for specific sample matrices and regulatory demands; reagents consist of binding resins, elution buffers, lysis buffers, and wash buffers that determine purity and yield characteristics; and services cover contract research and custom extraction services that provide flexibility for organizations without in-house capacity. These product distinctions inform purchasing decisions, validation timelines, and vendor selection criteria.

Workflow segmentation further differentiates market needs across DNA extraction, microbial extraction, plasmid extraction, RNA extraction, and viral nucleic acid extraction. Each workflow contains method-specific subtypes-such as column-based, magnetic bead-based, and organic extraction for DNA and RNA; chemical lysis and mechanical lysis for microbial extraction; and alkaline lysis or SDS-based methods for plasmid extraction-that influence consumable compatibility, automation potential, and assay sensitivity. Application-driven demand emerges across clinical diagnostics, drug discovery and development, forensic analysis, genomic research, and personalized medicine, each placing distinct regulatory, throughput, and quality requirements on sample prep choices. End users range from academic research laboratories and clinical laboratories to forensic and industrial labs, as well as pharmaceutical and biotechnology companies, with adoption patterns shaped by budget cycles, accreditation needs, and throughput expectations. Finally, automation tiers-fully automated, manual, and semi-automated-define the balance between capital expenditure and labor savings, shaping total cost of ownership considerations and influencing the pace at which labs adopt new platforms.

Examining how regional regulatory frameworks, procurement behaviors, and manufacturing capacity shape adoption and vendor strategy across major global markets

Regional dynamics significantly influence procurement strategies, regulatory compliance, and innovation adoption within the nucleic acid sample preparation space. The Americas demonstrate a strong emphasis on clinical diagnostics integration, translational research applications, and an appetite for high-throughput automation, with procurement cycles often tied to reimbursement policies and public health priorities. This creates an environment where validated kits and integrated instrument platforms gain traction, especially when coupled with reliable technical support and rigorous regulatory documentation. Comparative regulatory frameworks across countries within the region also affect time-to-deployment for diagnostic workflows.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in parts of Europe coexists with variable market maturity across the Middle East and Africa. Buyers in this region prioritize vendor support, CE-marked or regionally certified solutions, and flexible supply arrangements that account for cross-border logistics challenges. Localized training and language-specific documentation frequently influence vendor selection. The Asia-Pacific region is characterized by rapid capacity expansion, strong manufacturing capabilities, and a mixed adoption curve where cutting-edge academic centers coexist with emerging clinical markets. Here, cost-sensitive procurement coexists with aggressive adoption of automation and domestic reagent production, prompting international vendors to adapt commercial strategies to local price points and partnership models.

Evaluating competitive differentiation through platform interoperability, validated consumables, service capabilities, and sustainability commitments

Competitive dynamics in nucleic acid sample preparation are influenced by a combination of technological differentiation, breadth of consumable portfolios, and the ability to provide end-to-end validated workflows. Leading instrument manufacturers differentiate through platform interoperability, throughput scaling, and service networks that reduce downtime for clinical and high-throughput research customers. Kit and reagent suppliers compete on ease of integration with popular instruments, robustness across sample types, and the strength of validation data supporting clinical or research use cases. Service providers, including contract research organizations and custom extraction labs, carve niches by offering validated pipelines and rapid turnaround times for specialized sample types.

Strategic partnerships and cross-licensing arrangements between instrument vendors and reagent developers are frequent, enabling faster market entry for complete solutions and helping laboratories shorten validation timelines. Additionally, an increasing number of companies are investing in application support teams and training programs to reduce adoption friction, particularly for buyers transitioning from manual to automated workflows. Sustainability considerations, such as reduced plastic waste and recyclable consumables, are beginning to influence procurement choices and product development roadmaps, adding an additional dimension to competitive positioning.

Actionable strategies for vendors and laboratory leaders to accelerate adoption, de-risk supply chains, and align commercial models with customer workflows

Industry leaders can convert shifting market dynamics into strategic advantage by pursuing a set of focused, actionable initiatives. First, prioritizing modular platform design and open-source interoperability increases addressable use cases and reduces buyer reluctance around vendor lock-in, thereby expanding commercial reach. Second, investing in validated end-to-end workflows and robust technical documentation accelerates customer onboarding and shortens time-to-value, which is particularly important for clinical laboratory customers. Third, diversifying manufacturing and sourcing footprints mitigates exposure to tariff-driven cost pressures while improving resilience against disruption.

Beyond product and supply considerations, leaders should enhance commercial propositions through flexible pricing models, including reagent leasing, pay-per-test arrangements, and bundled service offerings that align with customers' operational budgets. Strengthening regional support networks and localized training initiatives will improve adoption rates in diverse regulatory environments, while targeted partnerships with clinical and academic centers can generate high-quality validation data and practitioner advocacy. Finally, embedding sustainability targets into product design and consumable lifecycle planning can differentiate vendors with forward-looking procurement mandates and help organizations align with institutional ESG objectives.

A rigorous mixed-methods research protocol combining practitioner interviews, technical literature, regulatory review, and cross-validation to ensure robust industry insights

The research approach underpinning this analysis combined primary and secondary methods to ensure triangulation and validation of thematic findings. Primary inputs included structured interviews with operational leaders in clinical laboratories, procurement managers at academic institutions, technical directors at contract research providers, and product managers at instrument and reagent suppliers. These engagements focused on real-world adoption challenges, validation considerations, and procurement priorities. Secondary inputs comprised peer-reviewed literature on extraction chemistries, regulatory guidance documents relevant to clinical diagnostics, patent filings that highlight innovation trajectories, and technical manuals from instrument vendors to understand integration capabilities.

Qualitative synthesis was complemented by cross-validation steps, where vendor claims about throughput and compatibility were contrasted against independent user testimony and regulatory documentation. Attention was paid to recent public policy changes affecting trade and tariffs to contextualize supply chain implications. Throughout the process, potential biases were managed by anonymizing primary respondent data and seeking multiple confirmations for critical assertions, resulting in a robust, practitioner-focused body of evidence that supports the strategic insights presented in this report.

Synthesizing strategic imperatives where automation, validated consumables, and resilient sourcing converge to enhance molecular assay performance

Nucleic acid sample preparation occupies a pivotal role in the molecular ecosystem, where improvements in extraction chemistry, automation, and validated workflows directly influence diagnostic sensitivity, research reproducibility, and operational throughput. The landscape will continue to be shaped by technological convergence-platforms that integrate hardware, consumables, and software-alongside shifting procurement behaviors driven by regional regulations, tariff environments, and institutional priorities. Vendors that align product roadmaps with customer pain points such as validation time, supply reliability, and total cost of ownership will be best positioned to capture durable demand.

For laboratories and corporate buyers, the imperative is to balance near-term operational resilience with strategic investments in automation and validated consumables that support future assay expansion. Building supplier diversity into sourcing strategies, engaging in collaborative validation exercises with vendors, and demanding transparent technical evidence will reduce deployment friction and enhance assay reliability. Taken together, these steps will enable organizations to harness the full potential of advances in sample preparation and translate them into measurable improvements in downstream molecular outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Sample Preparation Market, by Product

  • 8.1. Instruments
    • 8.1.1. Automated Extractors
    • 8.1.2. Centrifuges
    • 8.1.3. Vacuum Manifolds
  • 8.2. Kits
    • 8.2.1. Dna Extraction Kits
    • 8.2.2. Rna Extraction Kits
    • 8.2.3. Viral Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Binding Resins
    • 8.3.2. Elution Buffers
    • 8.3.3. Lysis Buffers
    • 8.3.4. Wash Buffers
  • 8.4. Services
    • 8.4.1. Contract Research
    • 8.4.2. Custom Extraction Services

9. Nucleic Acid Sample Preparation Market, by Workflow Type

  • 9.1. Dna Extraction
    • 9.1.1. Column Based
    • 9.1.2. Magnetic Bead Based
    • 9.1.3. Organic Extraction
  • 9.2. Microbial Extraction
    • 9.2.1. Chemical Lysis
    • 9.2.2. Mechanical Lysis
  • 9.3. Plasmid Extraction
    • 9.3.1. Alkaline Lysis
    • 9.3.2. SDS Based
  • 9.4. Viral Nucleic Acid Extraction

10. Nucleic Acid Sample Preparation Market, by Automation

  • 10.1. Fully Automated
  • 10.2. Manual
  • 10.3. Semi Automated

11. Nucleic Acid Sample Preparation Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Drug Discovery And Development
  • 11.3. Forensic Analysis
  • 11.4. Genomic Research
  • 11.5. Personalized Medicine

12. Nucleic Acid Sample Preparation Market, by End User

  • 12.1. Academic Research Laboratories
  • 12.2. Clinical Laboratories
  • 12.3. Forensic Laboratories
  • 12.4. Industrial Laboratories
  • 12.5. Pharmaceutical And Biotechnology Companies

13. Nucleic Acid Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nucleic Acid Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nucleic Acid Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nucleic Acid Sample Preparation Market

17. China Nucleic Acid Sample Preparation Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Aurora Biomed Inc.
  • 18.7. BGI Group
  • 18.8. Bio-Rad Laboratories, Inc.
  • 18.9. Bionano Genomics
  • 18.10. BIONEER CORPORATION
  • 18.11. Blue-Ray Biotech Corp.
  • 18.12. Danaher Corporation
  • 18.13. Eppendorf SE
  • 18.14. F. Hoffmann-La Roche Ltd
  • 18.15. Hamilton Company
  • 18.16. Illumina, Inc.
  • 18.17. LGC Biosearch Technologies
  • 18.18. Merck KGaA
  • 18.19. MP Biomedicals, LLC
  • 18.20. Nanjing Vazyme Biotech Co.,Ltd.
  • 18.21. Norgen Biotek Corp.
  • 18.22. Opentrons Labworks, Inc.
  • 18.23. PerkinElmer Inc.
  • 18.24. Promega Corporation
  • 18.25. QIAGEN N.V.
  • 18.26. RevoluGen Ltd
  • 18.27. Sansure Biotech Inc.
  • 18.28. Tecan Trading AG
  • 18.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 262. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (